Sartorius Stedim Biotech Reports Share Capital and Voting Rights

Sartorius Stedim Biotech SA, headquartered in Aubagne, France, released a statement on March 5, 2025, detailing its share capital and voting rights. As of February 28, 2025, the company reported a total of 97,330,405 shares issued. This corresponds to 165,560,355 theoretical voting rights, which include treasury shares. The company records a net voting right count of 165,528,295, excluding treasury shares.

The release of this information aligns with regulations under Article L 233-8-II of the French Code of Commerce and Article 223-6 of the General Regulations of the AMF. This detailed reporting ensures transparency in Sartorius Stedim Biotech SA's shareholder structure.